ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,831 | -63.2% | 10,514 | -55.5% | 0.01% | -64.3% |
| Q1 2023 | $513,601 | +57.1% | 23,603 | +17.1% | 0.01% | -26.3% |
| Q4 2019 | $327,000 | +6.5% | 20,153 | +129.8% | 0.02% | -29.6% |
| Q3 2019 | $307,000 | -38.0% | 8,768 | +29.4% | 0.03% | -22.9% |
| Q1 2019 | $495,000 | +123.0% | 6,774 | +94.6% | 0.04% | +150.0% |
| Q4 2018 | $222,000 | -55.2% | 3,481 | -26.9% | 0.01% | -60.0% |
| Q1 2018 | $495,000 | – | 4,760 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |